• Mashup Score: 0

    TUESDAY, Oct. 17, 2023 (HealthDay News) — Americans born in recent years can likely count on taking prescription drugs for about half their life, according to new research.For males born in 2019, it’s about 48% of their lives. For women, it’s 60% of their lifetime, the study found.“The years that p…

    Tweet Tweets with this article
    • “The desire to take medicine is perhaps the greatest feature which distinguishes man from animals.” - Sir William Osler. #Oncology #BCSM #LCSM #BTSM #GynCSM #MedOnc #RadOnc #Urology #GynOnc #Cancer #PanCan #PCSM https://t.co/dznbqJNnrz

  • Mashup Score: 0

    PURPOSE To understand the spectrum and volume of classical hematology (CH) referrals to hematology clinics at a National Cancer Institute (NCI)–designated cancer center (CC) to plan for the delivery of effective and equitable care for this population. METHODS One referral office at the Academic CC located in Bexar County, TX, handles all adult hematology referrals. From October 1, 2021, to September 30, 2022, all nonmalignant hematology (MH) referrals were triaged daily to define the category of CH problem. Declined referrals (confirmed at triage that no CH problem was evident) are included as part of this analysis. Electronic consultation (opinion rendered without patient seen) at our CC is available and is not part of this analysis. RESULTS One thousand nine hundred forty-five CH referrals were received in the 12-month period. Seventy-six referrals (3.9%) were declined. During the study period, there were 2,289 medical oncology referrals and 779 referrals for MH. CH referrals therefo

    Tweet Tweets with this article
    • 🩸 Classical #hematology (CH) referrals at an NCI-Designated Cancer Center comprise nearly 40% of all referrals to hematology & #MedOnc combined. Anemia & thrombosis represent nearly half of all CH referrals. ➡️ https://t.co/EACyXLPCDG @chasevwest @UTHealthSAMDA #HemOnc https://t.co/9Vcj5BepKy

  • Mashup Score: 8

    Registration is now open

    Tweet Tweets with this article
    • #ESMO23: where #oncology professionals meet to advance science in the field. Last week to benefit from preferential rates. Late registration deadline ⏰ 13 September. Register here: https://t.co/WdQQraJf9P @AndresC27622123 @Silke_Gillessen #MedOnc #CancerResearch #MedicalOncology https://t.co/dkIvr5cEpW

  • Mashup Score: 18

    Registration is now open

    Tweet Tweets with this article
    • #ESMO23 📢 Abstract authors & titles now online. Head to the programme & check out all the impressive science you can look forward to. While you are there, register now & benefit from reduced rates 👇 https://t.co/e64v1DMQpJ @AndresC27622123 @Silke_Gillessen #MedOnc https://t.co/GQvRJxxFpl